Recombinant vWF Concentrate and ECMO
NCT06118372
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Bleeding Disorder
Interventions
DRUG:
Recombinant von Willebrand Factor
Sponsor
University of Virginia